Effect of altered temperature storage on the in vitro cellular uptake of liposome drug products

Journal of Liposome Research

Volumn 20, Issue 2, 2010, Pages 178-182

  Volpe, Donna A ^a   Shaw, Arthur B ^a   Chen, Xiao Hong ^a   Zhou, Liang ^a   Chen, Mei Ling ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Liposomes; Stress; Temperature; Uptake

Indexed keywords

DAUNORUBICIN; DOXORUBICIN;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG STORAGE; DRUG UPTAKE; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; PRIORITY JOURNAL; TEMPERATURE STRESS;

ANIMALS; CELL LINE; DAUNORUBICIN; DOXORUBICIN; FEMALE; HUMANS; LIPOSOMES; MACROPHAGES; MICE; OVARIAN NEOPLASMS; TEMPERATURE;

EID: 77951648658     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982100903286493     Document Type: Article

References (26)

1. Ahsan, F., Rivas, I. P., Khan, M. A., Torres-Suárez, A. I. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers\liposomes and microspheres\on the phagocytosis by macrophages. J Contr Rel 79:29-40.
2. Allen, T. M., Austin, G. A., Chonn, A., Lin, L., Lee, K. C. (1991). Uptake of liposomes by cultured mouse bone marrow macrophages: infuence of liposome composition and size. Biochim Biophys Acta 1061:56-64.
3. Allen, T. M., Martin, F. J. (2004). Advantages of liposomal delivery systems for anthracyclines. Semin Oncol 31(Suppl 13):5-15.
4. Anderson, M., Omri, A. (2004). Te efect of diferent liposome components on the in vitro stability and release kinetics of liposome formulation. Drug Deliv 11:33-39.
5. Bajoria, R., Sooranna, S. R., Contractor, S. F. (1997). Endocytic uptake of small unilamellar liposomes by human trophoblast cells in culture. Hum Reprod 12:1343-1348.
6. Bhalerao, S. S., Raje Harshal, A. (2003). Preparation, optimization, characterization, and stability studies of salicylic acid lipo-somes. Drug Develop Ind Pharm 29:451-467.
7. Daleke, D. L., Hong, K., Papahadjopoulios, D. (1990). Endocytosis of liposomes by macrophages: binding, acidifcation, and leakage of liposomes monitored by a new fuorescence assay. Biochim Biophys Acta 1024:352-366.
8. El-Samaligy, M. S., Aff, N. N., Mahmoud, E. A. (2006). Evaluation of hybrid liposomes-encapsulated silmarin regarding physical stability and in vivo performance. Int J Pharm 319:121-129.
9. FDA/CDER. (2002). Draft guidance for industry. Liposome drug products: chemistry, manufacturing, and controls; human pharmacokinetics and bioavailability; and labeling documentation. Available at: http://www.fda.gov/ down-loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070570.pdf
10. Gabizon, A., Shmeeda, H., Barenholz, Y. (2003). Pharmacokinetics of pegylated liposomal doxorubicin: a review of animal and human studies. Clin Pharmacokinet 45:419-436.
11. Garg, M., Dutta, T., Jain, N. K. (2007). Stability of stavudine-loaded O-palmitoyl-anchored carbohydrate-coated liposomes. AAPS PharmSciTech 8:article 38.
12. Gill, P. S., Espina, B. M., Muggia, F., Cabriales, S., Tupule, A., Esplin, J. A., et al. (1995). Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 13:996-1003.
13. Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., et al. (2000). Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer 89:1037-1047.
14. Maitani, Y, Kawano, K., Yamada, K., Nagai, T., Takayama, K. (2001). Efciency of liposomes surface-modifed with soybean derived sterylglucoside as a liver targeting carrier in HepG2 cells. J Contr Rel 75:381-389.
15. Minko, T., Packunlu, R., Wang, Y, Khandare, J. J., Saad, M. (2006). New generation of liposomal drugs for cancer. Anti-Cancer Agents Med Chem 6:537-552.
16. Pietzyk, B., Henschke, K. (2000). Degradation of phosphatidylcholine liposomes containing carboplatin in dependence on composition and storage conditions. Int J Pharm 196:215-218.
17. Product Information. (2001). Doxil" doxorubicin HCl liposome injection. Ortho Biotech Products L.P., Raritan, New Jersey, USA.
18. Product Information. (2002). DaunoXome" daunorubicin citrate liposome injection. Gilead Sciences, Inc., San Dimas, California, USA.
19. Revelle, L. K., Lipe, T. G., Story, K. D., Doub, W. H. (2004a). Assessment of encapsulation efciency in liposomal drug products (LDPs) under various stress conditions. AAPS J 6: abstract 3011.
20. Revelle, L. K, Lipe, T. G, Doub, W. H. (2004b). Monitoring lipid degradation in liposomal drug products (LDPs) using HPLC with evaporative light scattering detection (ELS). AAPS J 6:abstract 2048.
21. Sadzuka, Y, Hirota, S. (1998). Does the amount of an antitumor agent entrapped in liposomes infuence its tissue distribution and cell uptake? Cancer Lett 131:163-170.
22. Samad, A., Sultana, Y, Aqil, M. (2007). Liposomal drug delivery systems: an update review. Curr Drug Deliv 4:297-305.
23. Storm, G., Crommelin, D. J. A. (1998) Liposomes: quo vadis? Pharm Sci Technol Today 1:19-31.
24. Tompson, A. K., Haisman, D., Singh, H. (2006). Physical stability of liposomes prepared from milk fat globule membrane and soya phospholipids. J Agric Food Chem 54:6390-6397. (Pubitemid 44367607)
25. Wang, Y, Eksborg, S., Lewensohn, R., Lindberg, A., Liliemark, E. (1999). In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulation of daunorubicin and doxorubicin in resistant K562 cells. Anti-Cancer Drugs 10:921-928.
26. Zhang, J. A., Pawelchak, J. (2000) Efect of pH, ionic strength, and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions. Part 1: Lipid hydrolysis. Eur J Pharm Biopharm 50:357-364.